Scrip

@PharmaScrip

Scrip goes beyond the headlines and focuses on delivering insight & analysis on the whole of the drug discovery, development and product life cycle value chain.

Global
Vrijeme pridruživanja: veljača 2009.

Tweetovi

Blokirali ste korisnika/cu @PharmaScrip

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @PharmaScrip

  1. prije 5 minuta

    Best Practices In Seasonal Vaccine Efficacy Studies: Tips For Successful Planning And Execution

    Poništi
  2. prije 1 sat

    Executives On The Move: Bayer Names Upcoming Information Chief And Legal Hires At Eli Lilly And CytoDyn

    Poništi
  3. prije 1 sat

    Did you know that the reach of is unparalleled with over 350 experts supplying comprehensive news & . Find out how to boost your sales with here

    Poništi
  4. prije 2 sata

    Zydus Cadila Explores Orphan Drug Indication For NASH Candidate

    Poništi
  5. prije 3 sata

    Biogen's Tecfidera Safe Following IPR Decision – For Now

    Poništi
  6. prije 4 sata

    Merck: It’s Not Just Keytruda Driving Future Growth

    Poništi
  7. prije 5 sati

    Merck To Spin Out A New Company, Following Industry's Downsizing Trend

    Poništi
  8. prije 17 sati

    Pharma Is Priority As GSK Confirms Split With Consumer

    Poništi
  9. prije 18 sati

    Novo Nordisk’s Positive Q4 Update Highlights Pipeline Plans

    Poništi
  10. prije 19 sati

    Cell And Gene Therapy Manufacturing: Catalent Snaps Up MaSTherCell

    Poništi
  11. prije 20 sati

    From too much data to the stuggles of patient recruitment, these are a few of the issues that came to light in a recent study by . Learn more of the solution here

    Poništi
  12. prije 22 sata

    Roche Has Blockbusters In Its Pipeline – But Demurs On Predicting Hits

    Poništi
  13. prije 23 sata

    Leo Sets Up For A David & Goliath Showdown In Atopic Dermatitis

    Poništi
  14. 5. velj

    Coronavirus Notebook: Regeneron, HHS To Develop Antibody

    Poništi
  15. 5. velj

    Ranitidine Recall Dents GSK India, Which Mulls Plant Sale

    Poništi
  16. 5. velj

    How are originator and industries diverging and to what extent to innovators want to play in the hybrid space? Download this article to find out

    Poništi
  17. 5. velj

    Japan Pharma Unconcerned About Virus Impact - For Now

    Poništi
  18. 5. velj

    A recent survey by has shed light on the potential for utlizing in precision-based . Register to learn more at our

    Poništi
  19. 5. velj

    Gilead Writes Down Kite Buy As Yescarta Sales Flatten Out

    Poništi
  20. 5. velj

    Leo Sets Up For A Samson & Goliath Showdown In Atopic Dermatitis

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·